Allergy Testing & Immunotherapy Training for Dentists

The course covers three primary diagnostic modalities: skin prick testing (the most common in-office method), intradermal testing (for confirmation of equivocal results), and serum-specific IgE blood panel interpretation. You will learn proper technique, allergen panel selection, result grading, and clinical correlation for each method, along with food sensitivity testing approaches and emerging diagnostic technologies.

Subcutaneous immunotherapy (SCIT) involves regular injections of allergen extracts administered in your office, typically weekly during the build-up phase and monthly during maintenance. Sublingual immunotherapy (SLIT) uses under-the-tongue drops or tablets that patients self-administer at home. The course covers both modalities in detail, including patient selection criteria, efficacy comparisons, safety profiles, and the business considerations for offering each approach.

Allergy testing and immunotherapy create a dual revenue stream — initial diagnostic testing generates $200-$600 per patient, and ongoing immunotherapy treatments produce $150-$400 per month in recurring revenue per patient. Practices with 50-100 active immunotherapy patients can generate $100K-$400K+ in annual allergy-related revenue. The recurring nature of immunotherapy makes this one of the most predictable revenue sources in outpatient medicine.

Yes, in-office allergy testing requires specific equipment and supplies including skin prick testing devices, allergen extract panels, control solutions, and immunotherapy preparation materials. The course includes detailed guidance on equipment selection, vendor recommendations, setup requirements, and cost analysis to help you make informed purchasing decisions. Most practices can establish a complete allergy testing capability for a modest initial investment.

Absolutely. This course is specifically designed for primary care providers, functional medicine practitioners, and other healthcare professionals who want to add allergy services to their existing practices. You do not need prior allergy or immunology training. The curriculum starts with foundational allergy science and progresses through hands-on testing techniques and immunotherapy protocols, giving you everything needed to treat allergy patients confidently.

Anaphylaxis prevention and emergency management is a critical safety component of the curriculum. You will learn risk assessment protocols, patient screening for high-risk factors, proper observation period requirements, early recognition of anaphylactic signs, epinephrine auto-injector and manual administration technique, and documentation requirements. All allergy providers must be prepared to manage severe allergic reactions, and Empire ensures you are fully trained in emergency response.

Allergic conditions significantly impact oral health through several pathways: chronic mouth breathing from nasal congestion leads to dry mouth (xerostomia), increasing cavity and periodontal disease risk; antihistamine medications further reduce salivary flow; allergic sinusitis can cause referred pain mimicking dental pathology; and allergies contribute to TMJ dysfunction through jaw positioning changes. Understanding these connections improves your diagnostic accuracy and treatment planning for affected patients.

Dental scope for allergy services varies by state. Some states authorize dentists to perform allergy testing within expanded scope provisions, particularly for allergens relevant to dental materials and head/neck conditions. Others may require a separate clinical entity or collaborative arrangement. The course provides the clinical knowledge; we recommend consulting your state dental board regarding the specific practice structure available in your jurisdiction.

Allergy testing generates $200–$600 per patient for initial diagnostics, and immunotherapy creates $150–$400 in monthly recurring revenue per patient. Even a modest allergy patient panel creates meaningful additional income that operates entirely outside dental insurance. The recurring nature of immunotherapy visits also increases your overall patient engagement frequency, creating opportunities for dental treatment discussions during allergy appointments.

In most states, dentists are authorized to administer botulinum toxin and dermal filler injections within the head, neck, and associated structures. Some states define this scope broadly to include cosmetic applications, while others limit dental injectable use to therapeutic and functional purposes. Empire recommends confirming your state dental board's specific guidelines. Our training provides the clinical certification recognized by dental boards nationwide.

Dentists have superior knowledge of facial anatomy, nerve pathways, and injection techniques compared to most other healthcare professionals entering aesthetics. Your daily experience with local anesthesia, precise needle placement, and patient management in the facial region gives you a significant head start. Empire's course builds on these existing competencies to add aesthetic-specific protocols, product knowledge, and treatment planning skills.

Dental practices that add aesthetic injectable services typically generate $100K-$300K+ in additional annual revenue, often from their existing patient base. Botox and filler treatments have high profit margins, create recurring revenue through maintenance appointments, and attract new patients who become dental patients as well. The crossover appeal is significant — patients who trust you with their smile naturally trust you with their facial aesthetics.